Registry of Lobbyists

Monthly Communication Report

371-516517

Organization: Innovative Medicines Canada/Médicaments novateurs Canada
Associated registration: 782797-371-92
Communication date: 2021-11-12
Posted date: 2021-12-03

Designated Public Office Holders who participated in the communication: Brandan Rowe, Director of Strategic Planning
Privy Council Office (PCO)

Kevin  Lavigne, Minister’s Office Deputy Chief of Staff
Privy Council Office (PCO)

Dominic LeBlanc, Minister of Intergovernmental Affairs, Infrastructure and Communities
House of Commons
 
Subject Matter of the communication: Science and Technology,  Regional Development,  Health,  Industry,  Infrastructure
 
Responsible Officer who filed this communication report: Pamela Fralick
 
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication.

The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
 

Date Modified: